A double-blinded randomized controlled trial with indomethacin versus placebo in women with preterm premature rupture of membranes (PPROM) between 24 and 32 weeks gestation
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Indometacin (Primary)
- Indications Preterm labour
- Focus Therapeutic Use
- 18 Mar 2015 Biomarkers information updated
- 10 Jul 2007 New trial record.